Acerus Pharmaceuticals Corporation
Records under this name other than the patents Acerus Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Acerus Pharmaceuticals Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,419,914 | Safe Desmopressin Administration Formerly held In force · High confidence | In force | High confidence | |
| US 9,925,232 | Methods and Compositions Comprising Desmopressin in Combination with a 5-Alpha Reductase Inhibitor Lapsed on the fee record Ended Mar 27, 2026 · High confidence | Lapsed on the fee record | Ended Mar 27, 2026 | High confidence |
| US 7,799,761 | Pharmaceutical Compositions Including Low Dosages of Desmopressin Term ended Term ended Sep 26, 2024 · Medium confidence | Term ended | Term ended Sep 26, 2024 | Medium confidence |
| US 7,405,203 | Pharmaceutical Compositions Including Low Dosages of Desmopressin Term ended Term ended May 6, 2023 · Medium confidence | Term ended | Term ended May 6, 2023 | Medium confidence |
| US 8,143,225 | Pharmaceutical Compositions Including Low Dosages of Desmopressin Term ended Ended no later than May 6, 2023 · Low confidence | Term ended | Ended no later than May 6, 2023 | Low confidence |